Paloma Partners’s CONMED CNMD Stock Holding History

Paloma Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,968	Closed	-$388K	–	1840
2021 Q1	$388K	Buy	+2,968	New	+$357K	0.01%	1310
2020 Q4	–	Sell	-13,945	Closed	-$1.1M	–	1726
2020 Q3	$1.1M	Buy	+13,945	New	+$1.14M	0.03%	686
2020 Q1	–	Sell	-4,132	Closed	-$462K	–	1372
2019 Q4	$462K	Buy	+4,132	New	+$440K	0.01%	1451
2019 Q2	–	Sell	-3,713	Closed	-$309K	–	1782
2019 Q1	$309K	Buy	+3,713	New	+$270K	0.01%	1302
2018 Q3	–	Sell	-9,000	Closed	-$659K	–	1596
2018 Q2	$659K	Buy	+9,000	New	+$612K	0.01%	906
2016 Q2	–	Sell	-13,162	Closed	-$552K	–	2168
2016 Q1	$552K	Buy	+13,162	New	+$517K	0.01%	1254
2015 Q4	–	Sell	-8,274	Closed	-$395K	–	1731
2015 Q3	$395K	Buy	+8,274	New	+$454K	0.01%	1159
2014 Q3	–	Sell	-5,774	Closed	-$255K	–	1050
2014 Q2	$255K	Buy	+5,774	New	+$262K	0.01%	853

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paloma Partners's CNMD Position: Q2 2021 in Review

Paloma Partners sold out of CONMED (CNMD) in Q2 2021, closing a stake of 2,968 shares — an estimated $388K sold.

Paloma Partners first reported a position in CNMD in Q2 2014 and held it in 8 quarters. The position peaked at $1.1M in Q3 2020. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

Paloma Partners reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
Paloma Partners sold 2,968 CONMED shares in Q2 2021, an estimated $388K.
Paloma Partners first reported a position in CONMED in Q2 2014 and held it in 8 quarters.
Paloma Partners's CONMED position peaked at $1.1M in Q3 2020.
252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.